Hybrid mRNA and protein vaccine induce 5x more antibodies in mice

Caltech scientists have developed a new type of vaccine that works like a hybrid of mRNA and protein nanoparticles. In tests in mice, the prototype produced five times more antibodies than existing COVID-19 vaccines, and could be put to work against a range of diseases.